• Join Today!

Become a member and connect with:

  • An Active Online Community
  • Articles and Advice on SCD
  • Help Understanding Clinical Trials
healthcare providers

Maureen Okam Achebe, MD, MPH

Healthcare Provider
Clinical Director
Non-Malignant Hematology Clinic
Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, Massachusetts, United States

Dr. Maureen M. Okam studied medicine at University of Port Harcourt Medical School (1995). Her interests are hematologic disorders, anemia, sickle cell disease and thalassemia, thrombosis and anticoagulant therapy, thrombocytopenia, myelodysplasia and myeloproliferative disorders.

Her current research focuses on the pre-clinical and clinical development of new agents for the treatment of hemoglobinopathies – sickle cell disease and thalassemia. Her on-going clinical evaluation of histone deacetylase inhibitors in the induction of fetal hemoglobin, is funded by the National Institutes of Health through a Harvard Blood Scholars research grant.

Clinical Director, Non-Malignant Hematology Clinic
Assistant Director, Brigham and Women’s Hospital Outpatient Infusion Center
Director, Brigham and Women’s Hospital Sickle Cell Program
Assistant Professor in Medicine, Harvard Medical School